Blue Ridge Capital

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 1, 2017	Exosome Diagnostics	$30.0M Series C	Forbion, Tiger Infrastructure Partners	Arcus Ventures, btov Partners, CD-Venture, NGN Capital
Jan 1, 2016	Exosome Diagnostics	$16.0M Series B	—	Arcus Ventures, Forbion, CD-Venture, NGN Capital, QIAGEN, Tiger Management

Total Raised

N/A

Valuation

N/A